Compare Direxion Daily Semiconductor Bear 3X Shares (SOXS) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily Semiconductor Bear 3X Shares vs UnitedHealth Group Inc — how do they compare? Direxion Daily Semiconductor Bear 3X Shares trades at $45.63, while UnitedHealth Group Inc trades at $436.35 (market cap $382.83B). The key difference: UnitedHealth Group Inc pays a 2.2% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| SOXS | UNH | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $1.61K | $431.68 |
52-Week Low | $32.50 | $237.77 |
Market Cap | — | $382.83B |
Enterprise Value | — | $429.52B |
Dividend Yield | — | 2.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $53.99, down 1.64% with a bearish moving average signal but bullish overall technical outlook. The ETF provides 3x leveraged inverse exposure to semiconductors, recently benefiting from sector volatility. A 1:10 stock split is scheduled for July 26, 2026, following a $0.04 dividend payment in June. Recent news highlights SOXS's surge during semiconductor sell-offs, with the ETF gaining attention as a tactical instrument amid AI-driven chip market fluctuations.
SOXS offers leveraged inverse exposure to semiconductor stocks, presenting high-risk, tactical opportunities during sector downturns. The bullish technical signal contrasts with overbought RSI readings, suggesting potential near-term volatility. Key risks include leverage decay, sector reversal momentum, and dependence on semiconductor market weakness. Investors should approach SOXS as a short-term hedging tool rather than a long-term holding due to its inverse structure and high volatility.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
